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MEDICINE AND SOCIETY 
Decreasing Smoking but Increasing Stigma? Anti-tobacco Campaigns, Public 
Health, and Cancer Care 
Kristen E. Riley, PhD, Michael R. Ulrich, JD, MPH, Heidi A. Hamann, PhD, and Jamie 
S. Ostroff, PhD 
 
Abstract 
Public health researchers, mental health clinicians, philosophers, and 
medical ethicists have questioned whether the public health benefits of 
large-scale anti-tobacco campaigns are justified in light of the potential 
for exacerbating stigma toward patients diagnosed with lung cancer. 
Although there is strong evidence for the public health benefits of anti-
tobacco campaigns, there is a growing appreciation for the need to better 
attend to the unintended consequence of lung cancer stigma. We argue 
that there is an ethical burden for creators of public health campaigns to 
consider lung cancer stigma in the development and dissemination of 
hard-hitting anti-tobacco campaigns. We also contend that health care 
professionals have an ethical responsibility to try to mitigate stigmatizing 
messages of public health campaigns with empathic patient-clinician 
communication during clinical encounters. 
 
Introduction  
Tobacco use remains the leading cause of preventable death in the United States, with 
cigarette smoking killing more than 480,000 Americans every year [1]. An estimated 
41,000 of these deaths among adults are attributable to secondhand smoke exposure 
[1]. Every day in the US more than 3,800 youths under the age of 18 smoke their first 
cigarette; an estimated 26 percent of these will become adult smokers [2]. 
 
Given the well-established health consequences of smoking, the public health 
community has established and maintained a comprehensive tobacco control effort, 
including restrictions on smoking in worksites and other public places, increased tobacco 
taxation, increased access to evidence-based tobacco treatment, and public health 
national media campaigns [3]. Collectively, this comprehensive tobacco control effort 
represents one of the leading public health success stories. In the 50 years since the 
1964 Surgeon General’s report, Smoking and Health, US adult smoking rates have fallen 
from 43 percent to 18 percent [4]. 
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Although what we’ll call “hard-hitting” anti-tobacco public health campaigns—those 
with fear-arousing messages—have been shown to be the most effective type of anti-
tobacco mass-reach health communication interventions, they might have the 
unintended consequence of stigmatizing those with smoking-related illnesses [5, 6]. In 
this paper, we explore the ethical dilemma whereby these campaigns are seen as helpful 
for public health in promoting smoking prevention and cessation but also potentially 
harmful for persons suffering from tobacco-related illnesses, including lung cancer. We 
discuss types of stigma and ethical implications, drawing upon concepts such as respect 
for persons. We then make recommendations for public health campaigns to incorporate 
counter-stigmatizing themes and for health care professionals to use empathic 
communication to mitigate the effects of stigma on patients with tobacco-related 
diseases. Finally, we provide direction for future research. 
 
Hard-Hitting Anti-tobacco Public Health Campaigns Are Effective in Reducing Smoking 
Prevalence 
Hard-hitting media anti-smoking campaigns often focus on both raising awareness 
about the health consequences of smoking and denormalizing smoking behavior, 
thereby motivating prevention among the general public and motivating smokers 
specifically toward cessation [7-9]. The term “hard-hitting” has been used to describe ad 
campaigns that are uncompromisingly direct, often with strong fear-arousing messages 
and personal stories about negative health consequences of smoking. These types of ads 
are supported by well-established theories of health behavior change (e.g., the Health 
Belief Model [10], the theory of planned behavior [11, 12]) that focus broadly on 
cognitive, emotional, and social processes (e.g., perceived susceptibility to disease, 
health beliefs regarding the consequences of behavior change, self-efficacy, and social 
norms) that predict behavior change. 
 
Hard-hitting ads have been shown to be more effective than humorous or neutral 
educational communication messages at reducing smoking [13]. Most recently, the Tips 
From Former Smokers™ campaign [14], featuring real people suffering from serious 
medical conditions as a result of smoking and exposure to secondhand smoke, has been 
credited with an estimated 1.64 million American smokers making a quit attempt; 
100,000 of these smokers are expected to maintain smoking abstinence [8]. Public 
health leaders assert that the hard-hitting ads are justified by the benefits observed in 
reducing smoking and related health consequences [5, 15-17]. Although some hard-
hitting anti-tobacco campaigns (e.g., graphic warnings on cigarette packs) have been 
challenged by the tobacco industry [18, 19], the Family Smoking Prevention and Tobacco 
Control Act of 2009 gives the FDA authority to regulate the tobacco industry [20]. 
Regardless of these legal challenges, hard-hitting anti-tobacco public health campaigns 
remain best practice for mass-reach public health communications. 
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Do Hard-Hitting Anti-tobacco Ad Campaigns Contribute to Stigma? 
There are several types of stigma that might be experienced by patients diagnosed with 
lung cancer: (1) anticipated stigma, or the expectation of discrimination, stereotyping, or 
prejudice; (2) enacted stigma, which involves actually experiencing discrimination, 
stereotyping, or prejudice; and (3) internalized stigma, which refers to people’s self-
endorsing negative feelings and beliefs about themselves [21]. While effective in 
decreasing smoking rates, hard-hitting anti-tobacco public health campaigns might 
increase the third kind of stigma. That is, internalization of stigma can result in negative 
self-appraisal and self-devaluation among persons diagnosed with lung cancer and 
other tobacco-related diseases [5, 6]. The majority of persons diagnosed with lung 
cancer report experiencing stigma, often related to guilt, regret, perceived blame, and 
other negative beliefs about smoking history [16, 22-24]. 
 
Stigma is associated with a number of deleterious psychosocial and medical outcomes in 
lung cancer patients, including delayed diagnoses [25-27], poor quality of life [26], and 
poor patient-clinician communication [28]. Although there has been limited investigation 
of stigma and long-term outcomes, stigma may have clear downstream effects, such as 
reduced treatment adherence and heightened psychosocial distress [24, 28]. One survey 
found that physicians were more likely to refer breast cancer patients than lung cancer 
patients for further therapy [29], which could be due to lung cancer stigma—the 
ubiquitous and damaging nature of which is well established [24, 28, 29]. 
 
Previous research has additionally pointed to differential rates of stigma experienced by 
lung cancer patients who used to or who currently smoke and those who have never 
smoked. Namely, lung cancer patients who have smoked and those who currently smoke 
report higher levels of stigma than those who have never smoked [26], although lung 
cancer patients who have never smoked also report experiencing stigma [26]. Given the 
epidemiology of lung cancer, health care professionals might assume that a patient’s 
lung disease is acquired “firsthand” as opposed to “secondhand” or without smoking 
exposure at all. As stigma is experienced by patients across this continuum of smoking 
exposures, the salience of this ethical debate is relevant for current, former, and never 
smokers—all those suffering from illnesses associated with smoking. 
 
An Ethical Dilemma 
While recognizing that the public health goals of tobacco prevention and cessation 
remain paramount, an ethical question arises as to whether these ads should continue to 
be hard-hitting or whether public health communication messages should be reframed 
to try to reduce stigma and blame that could be experienced by the 16 million Americans 
living with smoking-related diseases [30]. Looking at denormalization of smoking 
through a purely utilitarian lens renders a favorable assessment, as evidenced by a 12 
percent drop in the smoking rate of 18- to 29-year-olds in the US from 2005 to 2015 
[31]. However, when viewing hard-hitting anti-tobacco public health campaigns as 
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sanctioned social stigmatization in the context of people suffering from nicotine 
addiction and related medical illnesses, the “benefits” of these anti-tobacco ads should 
be tempered [32]. Internalized stigma (e.g., self-blame, shame, or guilt) could result in 
low self-esteem as people question their identity and self-worth. In its extreme form, 
stigma can be thought to “turn the individual into his own jailor, his own chorus of 
denunciation” [33]. 
 
Mental health clinicians caring for the psychosocial needs of cancer patients and health 
care ethicists have questioned whether the public health benefits are worth the 
“incidental” costs of stigma for individual patients [16, 34, 35]. Some health scientists 
have labeled anti-tobacco public health campaigns “demoralizing” [22] and “victim 
blaming” [6]. Additionally, hard-hitting campaigns could extend lung cancer stigma to 
any person who suffers from any smoking-related illness, regardless of the patient’s 
actual smoking history [24]. This “guilt by association” can be especially difficult for 
those with secondhand or even no prior tobacco exposure who perceive others’ negative 
attitudes as based on false assumptions about the nature and scope of their disease 
culpability. Given the current demographics of tobacco use, these campaigns might 
further stigmatize low-income and other vulnerable populations of smokers, who 
currently represent the majority of tobacco users [22]. And people who already feel 
disempowered tend to feel even more resentful, defensive, and demoralized after 
exposure to anti-tobacco campaigns [17, 36]. As a result, hard-hitting anti-tobacco ads 
could exacerbate health disparities and discourage access to high-quality health care. 
 
An important ethical question is how much iatrogenic stigma should matter if hard-
hitting campaigns are successful in preventing tobacco use and motivating smoking 
cessation as public health goals. Stigma and associated distress certainly matter at a 
level of clinicians interacting with individual patients diagnosed with lung cancer or other 
tobacco-related diseases. How much should an individual’s experience of stigma matter 
at a macro- and public health level of disease prevention? If the overarching goal is to 
reduce the negative health effects of tobacco use and smoking, whether the result of 
firsthand or secondhand use, the potential stigmatizing impact of anti-tobacco ads on 
those who are already suffering from tobacco-related illnesses such as lung cancer 
cannot be ignored. 
 
Stigma is not benign and has been shown to be associated with lung cancer patients’ 
avoidance or delay of seeking medical care [25], resulting in downstream risk of 
worsening lung cancer morbidity and mortality. While public health principles often 
emphasize prevention, stigma does not exclude those populations that prevention 
efforts have failed to reach. Meanwhile, the ethical principle of respect for persons and 
appreciating the intrinsic value of each individual requires that those who are suffering 
from tobacco-related illnesses, such as lung cancer, be treated with equity and justice. 
Health care professionals taking their ethical obligation of nonmaleficence seriously 
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should certainly be concerned about their roles in whether and how their individual 
patients experience stigma as a result of their specific actions or communications. 
 
What Should Be Done? 
Because anti-tobacco public health campaigns have been effective in reducing 
population smoking rates, banning hard-hitting ads completely would be shortsighted. 
Our attempt to raise awareness about the impact of lung cancer stigma is not to suggest 
that public health campaigns refrain from educating the public about the unquestionable, 
far-reaching health hazards of smoking. Rather, we offer several recommendations for 
addressing the iatrogenic consequences of hard-hitting anti-tobacco campaigns. 
 
First, public health campaigns could highlight counter-stigma themes. One such theme is 
the unscrupulous, predatory nature of big tobacco as an industry. Emphasizing how 
much money is spent annually by the tobacco industry on tobacco advertising and social 
marketing has been a compelling theme for prior anti-tobacco campaigns, particularly 
those targeting prevention of youth smoking [37-39]. The Lung Cancer Alliance’s 
campaign, “No One Deserves to Die of Lung Cancer,” serves as an excellent example of 
an effective public health campaign that acknowledges the dangerous nature of cigarette 
smoking while also emphasizing compassion and a nonjudgmental stance by using the 
ironic message that certain segments of the population (e.g., cat ladies, hipsters) deserve 
to die [40]. Ads that provide self-affirming messages (e.g., the value of raising a family or 
maintaining health) might buffer against defensive processing—dismissal of a health 
message perceived as personally threatening—because it has been shown that self-
affirmation prior to exposure to graphic images on cigarette pack warnings reduces such 
defensive processing [41]. Recent research shows that gain-framed messages—those 
that highlight benefits of quitting rather than costs of smoking—might be more effective 
for smokers who feel helpless and demoralized in their quitting efforts [42]. We also 
recommend ads that encourage the use of evidence-based smoking behavior change 
strategies and promote self-efficacy in quitting. Finally, given that lung cancer stigma 
can intersect with social and structural hierarchies such as power, culture, and privilege 
[43], it would seem important for public health campaigns to target all tobacco users, not 
just ethnic minorities and tobacco users of low socioeconomic status [32]. 
 
Second, health care professionals treating patients with lung cancer can communicate 
empathically to build patients’ resilience and try to help inoculate them to the 
stigmatizing effects of anti-tobacco health campaigns [6, 24, 26, 28]. One study found 
that physicians miss 90 percent of opportunities for demonstrating empathy in lung 
cancer care [44]. Physicians have noted the challenge of advising their patients to quit 
smoking while concurrently managing patients’ emotional distress following cancer 
diagnosis and treatment [6]. Good patient-clinician communication has been associated 
with lower levels of stigma in the health care setting [28]. Building resilience in lung 
cancer patients and those with tobacco-related illnesses through empathic responses 
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and problem-focused strategies may mitigate the negative consequences of stigma 
resulting from hard-hitting anti-tobacco campaigns [45]. We currently are working to 
develop and evaluate an empathic, nonjudgmental communication skills training module 
for health care professionals treating patients with lung cancer that focuses on taking a 
detailed tobacco history, advising current smokers to quit, and making a reliable referral 
for tobacco treatment services. 
 
Additional research is needed to determine how anti-tobacco campaigns can minimize 
the internalized stigma of patients living with tobacco-related diseases without 
compromising the campaigns’ strong public health effectiveness. For example, public 
health campaigns are often pretested using focus groups; new candidate ads could be 
assessed for whether and to what extent they generate stigma and unintended 
consequences such as shame and guilt. To our knowledge, the Tips campaign has not 
examined whether patients with lung and other tobacco-related conditions experience 
heightened stigma and regret. We recommend eliciting patient perspectives early in the 
development of anti-tobacco campaigns. There is much to be learned from other public 
health campaigns grappling with similar concerns (e.g., risky sexual and drug use 
behaviors and HIV/AIDS, alcohol and driving, obesity, and sun exposure). The Joint United 
Nations Programme on HIV/AIDS (UNAIDS) has suggested that negative views of people 
living with HIV can be attributed largely to stigma and ignorance about the harm of 
stigma and moral judgment, which is likely germane to those suffering from tobacco-
related diseases [46]. Accordingly, the HIV/AIDS public health community has made a 
concerted effort to examine the impact of stigma and embark on multipronged efforts to 
counter stigma with educational programs targeting specific vulnerable populations, in 




Overall, hard-hitting anti-tobacco public health campaigns work, although they might 
also inadvertently increase stigma among lung cancer patients, leading to deleterious 
downstream psychosocial and medical outcomes for this vulnerable population. Specific 
recommendations include shifting the focus of public health campaigns away from 
patient blaming and emphasizing clinician-level empathic communication interventions. 
Further research and attention are needed to ensure that hard-hitting anti-tobacco 
campaigns find the “sweet spot” for maximizing tobacco control while minimizing stigma 
experienced by lung cancer patients and those suffering from tobacco-related illnesses. 
Researchers, leaders of nonprofit organizations, government, hospital systems, health 
care professionals, and patient advocates can all be involved and accountable for 
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